# FDA Inspection 1122301 - Jeffrey G. Leflein, M.D. - March 20, 2020

Source: https://www.keypedia.com/records/fda_inspections/jeffrey-g-leflein-md/bcbc988b-15e6-4e4d-91e6-84c4cb1355b3
Source feed: FDA_Inspections

> FDA Inspection 1122301 for Jeffrey G. Leflein, M.D. on March 20, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122301
- Company Name: Jeffrey G. Leflein, M.D.
- Inspection Date: 2020-03-20
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1165017 - 2022-03-10](https://www.keypedia.com/records/fda_inspections/jeffrey-g-leflein-md/ac9ec418-1b7d-4b61-996d-86da2846de95)
- [FDA Inspection 833939 - 2013-05-14](https://www.keypedia.com/records/fda_inspections/jeffrey-g-leflein-md/63ea6748-f820-40f9-bb52-034b14706c52)

Company: https://www.keypedia.com/companies/jeffrey-g-leflein-md/7158e328-3976-4949-a7fb-1af1b4e0a3d4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c